CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an update on its ongoing transition to a commercial‑stage company following the first anniversary of ...
Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. Cognito Therapeutics announced a $105 million Series C round ...
Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. It was my privilege to attend J.P. Morgan’s annual healthcare ...
Neurotech’s Encelto is surgically implanted and delivers genetically modified cell therapy to the eye Neurotech Pharmaceuticals Inc.’s research efforts are paying off. The biotech company, focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results